<DOC>
	<DOCNO>NCT00191945</DOCNO>
	<brief_summary>Double blind clinical trial placebo control 153 child ( plan enrollment ) recent diagnosis ADHD . Patients randomized atomoxetine placebo arm ( 2:1 ) . The double blinded period last 12 week treatment open phase last 1 year , atomoxetine treatment administer . A gatekeeper strategy employ sequentially test secondary objective .</brief_summary>
	<brief_title>Efficacy Safety Atomoxetine Children With Recent Diagnosis Attention-Deficit/Hyperactivity Disorder ( ADHD )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>1 . Child adolescent patient must least 6 year age , must yet reach 16th birthday prior Visit 1 , inform consent obtain . 2 . Patients must meet Diagnostic Statistical Manual Mental Disorders , Fourth Edition Text Revision ( DSMIVTR ) diagnostic criterion ADHD . For purpose study diagnosis ADHD confirm Visit 1 administer KSADSPL . Patients must also ADHDRSIVParent : Inv score least 1.5 standard deviation age norm diagnostic subtype Visit 1 Visit 2 . In addition , must CGIADHDS score 4 Visit 1 Visit 2 . 3 . Patients must newly diagnose case ADHD . Newly diagnose case ADHD mean specialist ( include pediatrician , child psychiatrist , child neurologist ) child psychologist diagnose ADHD ( accord DSMIVTR International Statistical Classification Diseases Related Health Problems [ World Health Organisation ; 10th Revision ] [ ICD 10 ] criterion ) within 3 month prior Visit 1 . 1 . Patients history ADHD diagnosis longer 3 month prior Visit 1 . Diagnosis ADHD mean specialist ( include pediatrician , child psychiatrist , child neurologist ) child psychologist diagnose ADHD ( accord DSMIVTR ICD 10 criterion ) register medical record verbally inform parent diagnosis . 2 . Patients weigh less 20 kg study entry ( Visit 1 ) . If patient 's weight change Visit 1 value outside state range , patient still eligible , weight round near value within range dosing purpose .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>January 2010</verification_date>
</DOC>